Sinzinger H, Flores J, Widhalm K, Granegger S
Department of Nuclear Medicine, University of Vienna, Austria.
Eur J Nucl Med. 1988;14(7-8):358-61. doi: 10.1007/BF00254384.
Earlier results indicated a diminished labelling efficiency and recovery negatively linked to actual cholesterol and lipoprotein values in hyperlipoproteinemics. This study was designed to examine whether other alternative tracers exhibit similar results and to study the influence on platelet viability in the presence or absence of PGI2. We demonstrate that no substantial difference occurs between the four tracers concerning labelling efficiency and recovery in normo- and hypercholesterolemics. Cholesterol severely affects the labelling parameters for all the tracers to a comparable extent. The absolute platelet function varies considerably, however, the percent changes in normo- and hypercholesterolemics seen before and after the labelling procedure do not differ significantly. PGI2 improves recovery in general, however, without affecting labelling efficiency or in vitro viability testing. As prolonged incubation further increases labelling efficiency, the presence and extent of hyperlipoproteinemia should be known in order to avoid poor labeling and viability and subsequently poor clinical results.
早期结果表明,在高脂蛋白血症中,标记效率降低和回收率降低与实际胆固醇和脂蛋白值呈负相关。本研究旨在检查其他替代示踪剂是否表现出类似结果,并研究在有或没有前列环素(PGI2)的情况下对血小板活力的影响。我们证明,在正常胆固醇血症和高胆固醇血症患者中,四种示踪剂在标记效率和回收率方面没有实质性差异。胆固醇对所有示踪剂的标记参数都有相当程度的严重影响。绝对血小板功能差异很大,然而,标记程序前后正常胆固醇血症和高胆固醇血症患者的百分比变化没有显著差异。一般来说,PGI2可提高回收率,但不影响标记效率或体外活力测试。由于延长孵育时间会进一步提高标记效率,因此应该了解高脂蛋白血症的存在和程度,以避免标记不佳和活力降低,进而避免临床效果不佳。